Oral N-acetylcysteine reverses hyperoxia-related cough suppression in guinea pigs

Journal of Physiology and Pharmacology

Volumn 58, Issue SUPPL. 5, 2007, Pages 75-84

  Brozmanova, M ^a   Plevkova, J ^a   Bartos, V ^a   Plank, L ^a   Javorka, M ^a   Masar, J ^a   Tatar, M ^a  

^a University Teaching Hospital in Martin   (Slovakia)

Author keywords

Antioxidants; Citric acid induced cough; Hyperoxia; Mechanically induced cough; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; CITRIC ACID; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COUGHING; DRUG DOSE REGIMEN; DRUG EFFECT; GUINEA PIG; HYPEROXIA; MALE; MECHANICAL STIMULATION; NONHUMAN; OXIDATIVE STRESS; RESPIRATORY FUNCTION; SINGLE DRUG DOSE;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; CITRIC ACID; COUGH; DISEASE MODELS, ANIMAL; GUINEA PIGS; HYPEROXIA; LUNG; LUNG DISEASES; MALE; OXIDATIVE STRESS; PHYSICAL STIMULATION; REFLEX;

EID: 40449123950     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Quinlan T, Spivack S, Mossman BT. Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect 1994; 102Suppl 2: 79-87.
2. Lofaso F, Dauger S, Matrot B, Vardon G, Gaultier C, Gallego J. Inhibitory effects of repeated hyperoxia on breathing in newborn mice. Eur Respir J 2001; 29: 18-24.
3. Chen B, Guber A, Marom Z. Advance long-term oxygen therapy. RT International 1995: 55-60.
4. Tarpy SP, Celli BR. Long-term oxygen therapy. N Eng J Med 1995; 14: 710-714.
5. Clark JM, Lambertsen CJ: Pulmonary oxygen toxicity: A review. Pharmacol Rev 1971; 23: 37-132.
6. Klein J. Normobaric pulmonary oxygen toxicity. Anesth Analg 1990; 70: 195-207.
7. Jenkinson S. Oxygen toxicity. New Horizons 1993; 1: 47-57.
8. Kollarik M, Undem BJ. Plasticity of vagal afferent fibres mediating cough. In Cough: Causes, Mechanisms and Therapy. Malden, Blackwell 2003, pp. 181-192.
9. Mazzone SB, Canning BJ. Plasticity of the cough reflex. Eur Respir Rev 2002; 12: 236-242.
10. Brozmanova M, Hanacek J, Tatar M, Karcolova D, Szepe P. The influence of pure normobaric oxygen breathing for 48 h and 60 h on respiratory reflexes in guinea pigs. Eur Resp J 1996; 9Suppl 23: 131.
11. Brozmanova M, Hanacek J, Tatar M, Kollarik M. The influence of hyperoxia on cough reflex intensity in guinea pigs treated with bleomycin. Bratisl Lek Listy 2004; 105: 65-71.
12. Brozmanova M, Hanacek J, Tatar M, Strapkova A, Szepe P. Effects of hyperoxia and allergic inflammation on cough reflex intensity in guinea pigs. Physiol Res 2002; 51: 529-536.
13. Blesa S, Cortijo J, Mata M, Serrano A et al. Oral N-acetylcysteine attenuates the pulmonary inflammatory response to antigen. Eur Respir J 2003; 21: 394-400.
14. Christofidou-Solomidou M, Muzykantov VR. Antioxidant strategies in respiratory medicine. Treat Respir Med 2006; 5: 47-78.
15. Cotgreave IA. N-Acetylcysteine: pharmacological consideration and experimental and clinical application. Adv Pharmacol 1997; 38: 205-227.
16. Sjodin K, Nilsson E, Hallberg A, Tunek A. Metabolism of N-acetyl-1-cysteine. Biochem Pharm 1989; 38: 3981-3985.
17. Xiang A, Uchida Y, Nomura A et al. Effects of airway inflammation on cough response in the guinea pig. J Appl Phys 1998; 85: 1847-1854.
18. Korpas J, Tomori Z. Cough and other respiratory reflexes. Basel, Karger, 1979, p. 356.
19. Carr MJ, Lee LY. Plasticity of peripheral mechanisms of cough. Respir Physiol Neurobiol 2006; 152: 298-311.
20. Widdicombe J, Singh V. Physiological and pathophysiological down-regulation of cough. Respir Physiol Neurobiol 2006; 150: 105-117.
21. Pagano A, Barazzone-Argiroffo C. Alveolar cell death in hyperoxia-induced lung injury. Ann NY Acad Sci 2003; 1010: 405-416.
22. Jyonouchi H, Sun S, Abiru T, Chareancholvanich S, Ingbar DH. The effects of hyperoxic injury and antioxidant vitamins on death and proliferation of human small airway epithelial cells. Am J Respir Cell Mol Biol 1998; 19: 426-436.
23. Oldham KM, Bowen PE. Oxidative stress in critical care: is antioxidant supplementation beneficial? Am Diet Assoc 1998; 98: 1001-1008.
24. Jackson IM, Barnes J, Cooksey P. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study. J Int Med Res 1984; 12: 198-206.
25. Behr J, Maier K, Degenkolb B. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997; 156: 1897-1901.
26. Budinger GRS, Sznajder JI. To live or die: a critical decision for the lung. J Clin Invest 2005; 115: 828-830.
27. Langley SC, Kelly FJ. N-acetylcysteine ameliorates hyperoxic lung injury in the preterm guinea pig. Biochem Pharmacol 1993; 45: 841-846.
28. Shattuck KE, Rassin DK, Grinnell CD. N-acetylcysteine protects from glutathione depletion in rats exposed to hyperoxia. J Parenter Enteral Nutr 1998; 22: 228-233.
29. van Klaveren RJ, Dinsdale D, Pype JL, Demedts M, Nemery B. N-acetylcysteine does not protect against type II cell injury after prolonged exposure to hyperoxia in rats. Am J Physiol 1997; 273: 548-555.
30. Decramer M, Rutten-van Molken M, Dekhuijzen PR. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary diseases: a randomized placebo-controlled trial. Lancet 2005; 365: 1552-1560.